Effectiveness, pharmacokinetics, and safety of a new sustained-release leuprolide acetate 3.75-mg depot formulation for testosterone suppression in patients with prostate cancer: A phase III, open-label, international multicenter study

Autor: Marberger, Michael, Kaisary, Amir V, Shore, Neal D., Karlin, Gary S., Savulsky, Claudio, Mis, Ricard, Leuratti, Chiara, Germa, Josep R.
Zdroj: In Clinical Therapeutics 2010 32(4):744-757
Databáze: ScienceDirect
Externí odkaz: